Breakthrough small cell therapy targets hormonal imbalances, fertility, and menopausal symptoms using FDA-registered b ...

Older patients with Crohn’s disease are at elevated risk for recurrence following ileocolic resection but less frequently ...

Autoimmune Disease Therapeutics Market projected for significant growth from 2025 to 2035, driven by biologics, innovation, and rising prevalence Global demand for autoimmune disease therapeutics is ...

Feds file smuggling charge against Petrova after Judge Christina Reiss questioned a CBP officer's authority to strip her of ...

Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received seven years of orphan-drug exclusive approval from U.S.

She received a state-of-the-art bio-implant that has miraculously regulated the condition with minimal invasiveness — and ...

The Health Sciences Authority (HSA) has approved Dupixent (dupilumab) for adults as an add-on maintenance treatment for uncontrolled chronic obstructive pulmonary disease (COPD) characterized by ...

Future research into non-Hodgkin lymphoma treatments needs to explore long-term outcomes and a better understanding biologic ...

Q1 2025 revenue of $17.3 million, with product sales of $14.0 million, representing 76% growth over Q1 2024 and the 17th straight quarter of sequential product sales growthQ1 2025 basic and fully dilu ...

Among patients with RA, ACPA status significantly modifies the relationship between BMI and cardiovascular risk.

SEOUL, May 15 (Yonhap) -- Celltrion Inc., a leading South Korean biopharmaceutical company, said Thursday its business will ...

Mucus plugs affect some 40% to nearly 70% of COPD patients, and even clinically silent mucus plugs are linked to poorer ...